Meningioma other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Meningioma}} | {{Meningioma}} | ||
{{CMG}} {{AE}}{{HL}} | |||
==Overview== | |||
Bromodeoxyuridine labeling study may be helpful in the diagnosis of meningioma. An elevated bromodeoxyuridine labeling index is suggestive of both a rapid growth rate of meningioma and a greater incidence of recurrence following surgical resection.<ref name="pmid2399811">{{cite journal| author=Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB| title=Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. | journal=Acta Neuropathol | year= 1990 | volume= 80 | issue= 3 | pages= 311-7 | pmid=2399811 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2399811 }} </ref> | |||
==Bromodeoxyuridine Labeling Study== | |||
* An elevated bromodeoxyuridine labeling index of meningioma is associated with:<ref name="pmid2399811">{{cite journal| author=Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB| title=Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. | journal=Acta Neuropathol | year= 1990 | volume= 80 | issue= 3 | pages= 311-7 | pmid=2399811 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2399811 }} </ref> | |||
:* Rapid growth rate of the tumor | |||
:* Greater incidence of recurrence following surgical resection of the tumor | |||
==References== | ==References== | ||
{{Reflist| | {{Reflist|1}} | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
Revision as of 15:12, 27 September 2015
|
Meningioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Meningioma other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Meningioma other diagnostic studies |
|
Risk calculators and risk factors for Meningioma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
Bromodeoxyuridine labeling study may be helpful in the diagnosis of meningioma. An elevated bromodeoxyuridine labeling index is suggestive of both a rapid growth rate of meningioma and a greater incidence of recurrence following surgical resection.[1]
Bromodeoxyuridine Labeling Study
- An elevated bromodeoxyuridine labeling index of meningioma is associated with:[1]
- Rapid growth rate of the tumor
- Greater incidence of recurrence following surgical resection of the tumor
References
- ↑ 1.0 1.1 Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB (1990). "Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence". Acta Neuropathol. 80 (3): 311–7. PMID 2399811.